NCT06658535View on ClinicalTrials.gov

A Dose Escalation Study of NanO2 in Patients With Mild Respiratory Distress

PHASE1RecruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 13, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Mild Respiratory Distress
Interventions
DRUG

dodecafluoropentane (0.025 mL/kg)

dodecafluoropentane (0.025 mL/kg)

DRUG

dodecafluoropentane (0.032 mL/kg)

dodecafluoropentane (0.032 mL/kg)

DRUG

dodecafluoropentane (0.050 mL/kg)

dodecafluoropentane (0.050 mL/kg)

Trial Locations (2)

T6L 5X8

NOT_YET_RECRUITING

Grey Nun Community Hospital, Edmonton

H1T 2M4

RECRUITING

Hôpital Maisonneuve Rosemont, Montreal

All Listed Sponsors
lead

NuvOx LLC

INDUSTRY